Aardvark Therapeutics, Inc. Common Stock
General ticker "AARD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $146.0M (TTM average)
Aardvark Therapeutics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -11.4%.
Estimated limits based on current volatility of 11.8%: low 1.11$, high 1.40$
Factors to consider:
- Total employees count: 40 (+81.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Limited operating history, Need additional capital, Regulatory and compliance, Product development failure, Intellectual property risks
Short-term AARD quotes
Long-term AARD plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $7.42MM | $22.79MM | $62.73MM |
| Operating Income | $-7.42MM | $-22.79MM | $-62.73MM |
| Non-Operating Income | $0.21MM | $2.20MM | $5.13MM |
| R&D Expense | $4.48MM | $17.36MM | $48.94MM |
| Income(Loss) | $-7.21MM | $-20.59MM | $-57.59MM |
| Net Income(Loss)* | $-7.21MM | $-20.59MM | $-57.59MM |
| Stockholders Equity | $-34.80MM | $-54.64MM | $106.63MM |
| Assets | $10.54MM | $77.51MM | $117.18MM |
| Operating Cash Flow | $-5.82MM | $-18.09MM | $-54.17MM |
| Capital expenditure | $0.00MM | $0.11MM | $0.10MM |
| Investing Cash Flow | $0.00MM | $-12.00MM | $-49.67MM |
| Financing Cash Flow | $0.00MM | $81.99MM | $89.25MM |
| Earnings Per Share** | $-0.34 | $-0.95 | $-2.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.